PCV6- COST OF SECOND LINE PHARMACEUTICAL MANAGEMENT OF ATRIAL FIBRILLATION IN FRANCE
Abstract
Authors
L Annemans K Moeremans E Aliot P de Jong
L Annemans K Moeremans E Aliot P de Jong
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now